Presenter Name Title Organization.

Slides:

Advertisements

Similar presentations

Patients’ Perspective on HTA and Off-label use David Head MBA Chief Executive RP Fighting Blindness 25th Annual EuroMeeting 4-6 March 2013 RAI, Amsterdam.

Advertisements

Data Monitoring Models and Adaptive Designs: Some Regulatory Experiences Sue-Jane Wang, Ph.D. Associate Director for Adaptive Design and Pharmacogenomics,

Orphan Drugs: Where have we been; Where are we now; Where are we going Marlene E. Haffner, MD, MPH Haffner Associates, LLC 11 October,

MOTOROLA and the Stylized M Logo are registered in the US Patent & Trademark Office. All other product or service names are the property of their respective.

Type presentation name here in slide master © 2007 SDL. Company Confidential. Forward-looking information is based upon multiple assumptions and uncertainties.

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.

Introduction to Drug Rediscovery John Lisman Attorney-at-law Lisman Legal Life sciences Insert your logo in this area then delete this text box.

How to audit the role of the vendor in the conduct of outsourced studies Kristel Van de Voorde Director Global Quality Regulatory Compliance Bristol-Myers.

Presenter Name Title Organization Twitter Handle Insert your logo here, then delete text.

Quick Thoughts on PGP Use Cases for KMIP 1 Michael Allen Sr. Technical Director.

Click to add Presentation Title Arial 32, 5 line max title space line 3, title space line 4, title space line 5 Presenter Title Organization Insert your.

1 Optimal Strategies for Preparing Integrated and Clinical Summaries for a New Drug Application: Making it Work Under Any Circumstance Lisa A. Pierchala,

Bayesian approach to equivalence study of medical device 1 1.

Join us on Twitter: #AU2014. Class summary text goes here Class summary.

Join us on Twitter: #AU2013.  An appropriate image has been provided for your presentation based on the AU look and feel  You can replace the Title.

Sherri de Coronado Enterprise Vocabulary Services NCI Center for Bioinformatics and Information Technology March 11, 2009 A Terminology.

Making Comments Count for High-Impact Regulations and Guidelines in the US Virginia (Ginny) Beakes-Read Executive Director, Global Regulatory Policy and.

Strategic Analyses and Interpretation: Regulatory Intelligence for Decision Making Amy N. Grant Director, Regulatory Strategy & Science ViroPharma Incorporated.

Good Laboratory Practices and Inspection Readiness Paul Swidersky President/Sr. Consultant Quality Associates, Inc.

Meredith Brown-Tuttle, RAC Director APT Pharmaceuticals, Inc.

DIA ERS SIAC IND CMC eCTD Submissions Part II – IND to NDA

Process-based Metadata From a DIA Presentation: eTMF – Migrating from Paper Trial Master Files to Electronic Eldin Rammell, Managing Director, Rammell.

Experiences from building a lessons- learned database for regulatory interactions Åsa Rembratt Sr Reg Intelligence Manager Novo Nordisk A/S 26th Annual.

Group Sequential Tests for Delayed Responses Christopher Jennison Department of Mathematical Sciences University of Bath Lisa Hampson Department of Mathematics.

Making Comments Count for High-Impact Regulations and Guidelines in Canada, EU, Japan, and US Chairperson: Amy N. Grant Director, Regulatory Strategy &

Gabor Fari Life Sciences Solution Strategist Microsoft Corporation

Session Title Date ǀ Time

- A “Portable” Implementation

Mutagenic Impurities: Guidances Update w/ CMC Perspectives

Presenter Title Organization

Track 11 Symposium 27 June :30 – 3:00 PM

Clinical Trial Disclosure:

Perspective on GCP Warning Letters

Molly Butler Auditor II Quality Associates, Inc.

Interactive Session: Presentation of Scenarios and Q&A

Presentation Title Presenter(s) name(s) and job title(s), if needed

Community-Based and Cluster-Randomized Studies –‘Pragmatic’ Approaches for Life Cycle Evidence? Florian Eichmann, PhD Principal Scientific Affairs and.

FirstPoint and FirstDoc Application of the DIA EDM Reference Model

Presenter Name Title Organization.

1 Topic Title First slide 2 line 3 line 4 line

1 Topic Title First slide 2 line 3 line 4 line

Birmingham, UK, 2nd - 5th September 2018

Main point 6 point smaller than slide title

PMI® Leadership Institute Meeting 2018―EMEA

Chapter 3 Image Slides Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display.

Author Author’s Company

PMI® EMEA Congress 2018 Session Title Session Date | Time

ე ვ ი ო Ш Е Т И О А С Д Ф К Ж З В Н М W Y U I O S D Z X C V B N M

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug.

1 Session Title 2 line 3 line 4 line

Title Chapter 22 Image Slides

ATTN Presenters – please review and remove this slide from your PowerPoint deck before uploading.

Session Title Date ǀ Time

Birmingham, UK, 2nd - 5th September 2018

Presentation Title Presenter(s) name(s) and job title(s), if needed

DFI PowerPoint Presentation Guidelines

Author Author’s Company

1 Session Title 2 line 3 line 4 line

1 Topic Title First slide 2 line 3 line 4 line

1 Topic Title First slide 2 line 3 line 4 line

Author Author’s Company

UPEC rd International Universities Power Engineering Conference

UPEC th International Universities Power Engineering Conference

“[Provider Name] has met the standards and requirements of the Registered Continuing Education Program. Credit earned on completion of this program will.

“[Provider Name] has met the standards and requirements of the Registered Continuing Education Program. Credit earned on completion of this program will.

William W. Gregory for the CIOMS MLG Exploratory Team Pfizer Inc

UPEC th International Universities Power Engineering Conference

is a Registered Provider with The American Institute of Architects Continuing Education Systems. Credit earned on completion of this program.

SESSION TITLE Session # <insert number here> Date Month Year

SESSION TITLE Session #<insert number here> Date Month Year

Presentation transcript:

Presenter Name Title Organization

Disclaimer The views and opinions expressed in the following PowerPoint slides are those of the individual presenter and should not be attributed to Drug Information Association, Inc. (“DIA”), its directors, officers, employees, volunteers, members, chapters, councils, Communities or affiliates, or any organization with which the presenter is employed or affiliated. These PowerPoint slides are the intellectual property of the individual presenter and are protected under the copyright laws of the United States of America and other countries. Used by permission. All rights reserved. Drug Information Association, Drug Information Association Inc., DIA and DIA logo are registered trademarks. All other trademarks are the property of their respective owners.

Title of Slide Content: (Create presentation information here) Minimum recommended font size of 28 Maximum recommended number of lines to be displayed per page is 8 Keep information on the screen and away from the edges. File Naming Criteria: Keep it short, no slashes or commas etc.: Smith_J_reference_v1

Thank You Presenter Name Title Organization Your Twitter Handle Join the conversation #DIA2017